Several studies have shown that the expression of CAF-related markers such as α-smooth muscle actin (α-SMA), fibroblast activation protein (FAP), and platelet-derived growth factor receptor-α (PDGFR-α) can be used as diagnostic and prognostic markers for gastric cancer. This evidence concerns the gene FAP and gastric cancer.